OBJECTIVE: The corpus callosum, the largest white matter tract in the brain, is a midline structure associated with the formation of the hippocampus, septum pellucidum, and cingulate cortex, which have been implicated in the pathogenesis of schizophrenia. Corpus callosum shape deformation, therefore, may reflect a midline neurodevelopmental abnormality. METHOD: Corpus callosum area and shape were analyzed in 14 first-episode psychotic patients with schizophrenia, 19 first-episode psychotic patients with affective disorder, and 18 normal comparison subjects. RESULTS: No statistically significant corpus callosum area differences between groups were found, but there were differences in the structure's shape between the patients with schizophrenia and the comparison subjects. A correlation between width and angle of the corpus callosum was found in patients with affective disorder. CONCLUSIONS: Corpus callosum shape abnormalities in first-episode psychotic patients with schizophrenia may reflect a midline neurodevelopmental abnormality.
OBJECTIVE: The corpus callosum, the largest white matter tract in the brain, is a midline structure associated with the formation of the hippocampus, septum pellucidum, and cingulate cortex, which have been implicated in the pathogenesis of schizophrenia. Corpus callosum shape deformation, therefore, may reflect a midline neurodevelopmental abnormality. METHOD: Corpus callosum area and shape were analyzed in 14 first-episode psychoticpatients with schizophrenia, 19 first-episode psychoticpatients with affective disorder, and 18 normal comparison subjects. RESULTS: No statistically significant corpus callosum area differences between groups were found, but there were differences in the structure's shape between the patients with schizophrenia and the comparison subjects. A correlation between width and angle of the corpus callosum was found in patients with affective disorder. CONCLUSIONS: Corpus callosum shape abnormalities in first-episode psychoticpatients with schizophrenia may reflect a midline neurodevelopmental abnormality.
Authors: J E Downhill; M S Buchsbaum; T Wei; J Spiegel-Cohen; E A Hazlett; M M Haznedar; J Silverman; L J Siever Journal: Schizophr Res Date: 2000-05-05 Impact factor: 4.939
Authors: J R DeQuardo; M S Keshavan; F L Bookstein; W W Bagwell; W D Green; J A Sweeney; G L Haas; R Tandon; N R Schooler; J W Pettegrew Journal: Biol Psychiatry Date: 1999-05-15 Impact factor: 13.382
Authors: Y Hirayasu; M E Shenton; D F Salisbury; C C Dickey; I A Fischer; P Mazzoni; T Kisler; H Arakaki; J S Kwon; J E Anderson; D Yurgelun-Todd; M Tohen; R W McCarley Journal: Am J Psychiatry Date: 1998-10 Impact factor: 18.112
Authors: Alexei M C Machado; Tony J Simon; Vy Nguyen; Donna M McDonald-McGinn; Elaine H Zackai; James C Gee Journal: Brain Res Date: 2006-12-13 Impact factor: 3.252
Authors: Christopher L Adamson; Amanda G Wood; Jian Chen; Sarah Barton; David C Reutens; Christos Pantelis; Dennis Velakoulis; Mark Walterfang Journal: Hum Brain Mapp Date: 2011-02-08 Impact factor: 5.038
Authors: Serge A Mitelman; Yekaterina K Nikiforova; Emily L Canfield; Erin A Hazlett; Adam M Brickman; Lina Shihabuddin; Monte S Buchsbaum Journal: Schizophr Res Date: 2009-08-26 Impact factor: 4.939
Authors: James J Levitt; Carl Fredrik Westin; Paul G Nestor; Raul S J Estepar; Chandlee C Dickey; Martina M Voglmaier; Larry J Seidman; Ron Kikinis; Ferenc A Jolesz; Robert W McCarley; Martha E Shenton Journal: Biol Psychiatry Date: 2004-01-15 Impact factor: 13.382
Authors: Soon Beom Hong; Yong-Wook Shin; Sun Hyung Kim; So Young Yoo; Jong-Min Lee; In Young Kim; Sun I Kim; Jun Soo Kwon Journal: Eur Arch Psychiatry Clin Neurosci Date: 2007-04-26 Impact factor: 5.270
Authors: Li Yao; Su Lui; Wei Deng; Min Wu; Lizhou Chen; Yuan Xiao; Sunima Lama; Wenjing Zhang; Xiaoqi Huang; Tao Li; Qiyong Gong Journal: MAGMA Date: 2013-10-08 Impact factor: 2.310